ATE516040T1 - Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis - Google Patents

Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis

Info

Publication number
ATE516040T1
ATE516040T1 AT05794086T AT05794086T ATE516040T1 AT E516040 T1 ATE516040 T1 AT E516040T1 AT 05794086 T AT05794086 T AT 05794086T AT 05794086 T AT05794086 T AT 05794086T AT E516040 T1 ATE516040 T1 AT E516040T1
Authority
AT
Austria
Prior art keywords
composition
preventing
treating stomatitis
pharmaceutically acceptable
stomatitis
Prior art date
Application number
AT05794086T
Other languages
German (de)
English (en)
Inventor
Satoru Furukawa
Kenjiro Shimada
Dean Jones
Thomas Ziegler
Original Assignee
Kyowa Hakko Bio Co Ltd
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co Ltd, Univ Emory filed Critical Kyowa Hakko Bio Co Ltd
Application granted granted Critical
Publication of ATE516040T1 publication Critical patent/ATE516040T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT05794086T 2004-09-03 2005-09-02 Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis ATE516040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60705304P 2004-09-03 2004-09-03
PCT/US2005/031364 WO2006028991A2 (en) 2004-09-03 2005-09-02 Composition and method for prevention or treatment of stomatits

Publications (1)

Publication Number Publication Date
ATE516040T1 true ATE516040T1 (de) 2011-07-15

Family

ID=36036881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05794086T ATE516040T1 (de) 2004-09-03 2005-09-02 Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis

Country Status (7)

Country Link
US (1) US8067537B2 (enExample)
EP (1) EP1789068B1 (enExample)
JP (1) JP5066448B2 (enExample)
CN (1) CN101027078B (enExample)
AT (1) ATE516040T1 (enExample)
CA (1) CA2578748C (enExample)
WO (1) WO2006028991A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5408882B2 (ja) * 2008-01-23 2014-02-05 ヤマサ醤油株式会社 唾液分泌促進剤
EP2990048B1 (en) * 2013-01-21 2023-03-01 Kyowa Hakko Bio Co., Ltd. Nitric oxide concentration elevating agent
JP6582983B2 (ja) * 2013-07-31 2019-10-02 味の素株式会社 癌化学療法時の副作用軽減剤
DK3006045T3 (en) 2014-10-07 2017-07-17 Cyprumed Gmbh Pharmaceutical formulations for oral administration of peptide or protein drugs
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
EP3359181A1 (en) 2015-10-07 2018-08-15 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide drugs
EP3485871B1 (en) 2016-07-14 2025-12-24 Resonac Corporation Non-therapeutic use of an orotic acid derivative for inhibiting melanin production and whitening the skin
EP3622957A4 (en) * 2017-05-12 2021-01-27 Furukawa Research Office Co., Ltd. IMPROVING THE DEGREE OF ARTERIAL SATURATION WITH OXYGEN
JP7874258B2 (ja) * 2020-03-31 2026-06-16 株式会社古川リサーチオフィス 亜鉛化合物配合組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2250553A (en) * 1938-04-18 1941-07-29 Simon L Ruskin Medicinal preparation
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US4975434A (en) * 1986-05-27 1990-12-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antiviral and anticancer cyclopentenyl cytosine
US5204114A (en) 1992-03-30 1993-04-20 Health Maintenance Programs, Inc. Methods of manufacturing high dosage glutathione the tablets and capsules produced thereby
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
WO1998029101A1 (en) 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
EP1402892A4 (en) 2001-06-11 2006-11-08 Kyowa Hakko Kogyo Kk Antiinflammatoric and antitussive compositions
JP2005530738A (ja) * 2002-04-16 2005-10-13 アイシス・イノヴェイション・リミテッド 組織障害の予防及び／又は治療のためのクルクミン
JP2003321356A (ja) * 2002-05-01 2003-11-11 Rohto Pharmaceut Co Ltd 催乳作用を有する組成物
US7625928B2 (en) * 2002-10-01 2009-12-01 Mitos Pharmaceuticals, Inc. Nitroxide radioprotector formulations and methods of use
JP4731321B2 (ja) 2003-07-22 2011-07-20 協和発酵バイオ株式会社 ウィルス感染症の予防または治療用組成物

Also Published As

Publication number Publication date
WO2006028991A3 (en) 2006-04-27
HK1099918A1 (en) 2007-08-31
EP1789068A4 (en) 2007-10-17
CN101027078B (zh) 2012-07-04
JP2008512381A (ja) 2008-04-24
US20070259024A1 (en) 2007-11-08
US8067537B2 (en) 2011-11-29
JP5066448B2 (ja) 2012-11-07
CA2578748C (en) 2014-10-14
EP1789068A2 (en) 2007-05-30
EP1789068B1 (en) 2011-07-13
WO2006028991A2 (en) 2006-03-16
CA2578748A1 (en) 2006-03-16
CN101027078A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
ATE513550T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
EP1896083A4 (en) METHOD FOR THE TREATMENT OF POMPE DISEASE WITH 1-DESOXYNO-JIMIMYCIN AND DERIVATIVES
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602006010401D1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
EP1572075A4 (en) METHOD OF TREATING DISEASES ASSOCIATED WITH ABNORMAL KINASE ACTIVITY
EP1755661A4 (en) USE OF GELSOLIN FOR THE TREATMENT OF INFECTIONS
DE60328517D1 (de) Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE499105T1 (de) Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
DE602004020674D1 (de) 1-benzoyl-piperazin-derivate als glycin-aufnahmehemmer zur behandlung von psychosen
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
EP1635801A4 (en) METHOD FOR TREATING AND PREVENTING CARDIAC ARTHYTHMIA
DE60335647D1 (de) Pyrroloquinoline quinone und ein betablocker zur behandlung von ischämie oder reperfusionsschäden
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
ATE328880T1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
ATE460166T1 (de) Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie
ATE362923T1 (de) 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
EP1789068A4 (en) COMPOSITION AND METHOD FOR PREVENTING OR TREATING STOMATITIS
DE602005010222D1 (de) Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE60325496D1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties